Moxetumomab Pasudotox-tdfk and Relistor (Methylnaltrexone Tablets)
Determining the interaction of Moxetumomab Pasudotox-tdfk and Relistor (Methylnaltrexone Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: methylnaltrexone
Brand name: Relistor
Synonyms: Relistor
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Relistor Oral
- Moxetumomab Pasudotox-tdfk-Relistor Tablets
- Moxetumomab Pasudotox-tdfk-Relnate DHA
- Moxetumomab Pasudotox-tdfk-Relpax
- Moxetumomab Pasudotox-tdfk-Relyyks
- Moxetumomab Pasudotox-tdfk-Relyyks Patch
- Relistor (Methylnaltrexone Tablets)-Moxetumomab pasudotox-tdfk Intravenous
- Relistor (Methylnaltrexone Tablets)-Moxifloxacin
- Relistor (Methylnaltrexone Tablets)-Moxifloxacin (Systemic)
- Relistor (Methylnaltrexone Tablets)-Moxifloxacin Hydrochloride
- Relistor (Methylnaltrexone Tablets)-Moxifloxacin Injection
- Relistor (Methylnaltrexone Tablets)-Moxifloxacin Intravenous